Odd Brørs
Position:
Phone:
Email:
 

Author network for Odd Brørs by COREMINE medical


Publications 2016

Narum S, Brørs O, Stokland O, Kringen MK (2016)
Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a Level 1 trauma centre
BMC Emerg Med, 16 (1), 29
PubMed 27485307

Publications 2015

Opdal MS, Arnesen M, Müller LD, Hullstein I, Sayed K, Brørs O, Kringen M, Sagedal S, Gjesdal K, Krajci P (2015)
Effects of Hemodialysis on Methadone Pharmacokinetics and QTc
Clin Ther, 37 (7), 1594-9
PubMed 25963997

Publications 2013

Narum S, Solhaug V, Myhr K, Brørs O, Kringen MK (2013)
Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system
Eur J Clin Pharmacol, 69 (7), 1445-52
PubMed 23423243

Publications 2012

Fretheim A, Odgaard-Jensen J, Brørs O, Madsen S, Njølstad I, Norheim OF, Svilaas A, Kristiansen IS, Thürmer H, Flottorp S (2012)
Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
BMC Med, 10, 33
PubMed 22480336

Publications 2011

Hovda KE, Julsrud J, Øvrebø S, Brørs O, Jacobsen D (2011)
Studies on ethylene glycol poisoning: one patient - 154 admissions
Clin Toxicol (Phila), 49 (6), 478-84
PubMed 21824058

Narum S, Solhaug V, Myhr K, Johansen PW, Brørs O, Kringen MK (2011)
Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system
Br J Clin Pharmacol, 71 (2), 254-62
PubMed 21219407

Publications 2010

Kringen MK, Haug KB, Grimholt RM, Stormo C, Narum S, Opdal MS, Fosen JT, Piehler AP, Johansen PW, Seljeflot I, Berg JP, Brørs O (2010)
Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction
J Biomed Biotechnol, 2011, 739751
PubMed 21127708

Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
Reduced platelet function and role of drugs in acute gastrointestinal bleeding
Basic Clin Pharmacol Toxicol, 108 (3), 194-201
PubMed 21118353

Publications 2009

Gudex C, Hoffmann M, Brørs O, Dahlqvist R (2009)
[GPs' perceptions of the Institute for Rational Pharmacotherapy]
Ugeskr Laeger, 171 (7), 522-6
PubMed 19210936

Sharikabad MN, Aronsen JM, Haugen E, Pedersen J, Møller AS, Mørk HK, Aass HC, Sejersted OM, Sjaastad I, Brørs O (2009)
Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance
Am J Physiol Heart Circ Physiol, 296 (3), H787-95
PubMed 19136604

Vevelstad M, Pettersen S, Tallaksen C, Brørs O (2009)
O-demethylation of codeine to morphine inhibited by low-dose levomepromazine
Eur J Clin Pharmacol, 65 (8), 795-801
PubMed 19308365

Publications 2008

Gudmundsdottir H, Brørs O, Os I (2008)
[Metformin should not be used by patients with reduced renal function]
Tidsskr Nor Laegeforen, 128 (8), 936-7
PubMed 18431417

Haug KB, Sharikabad MN, Kringen MK, Narum S, Sjaatil ST, Johansen PW, Kierulf P, Seljeflot I, Arnesen H, Brørs O (2008)
Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
Thromb J, 6, 7
PubMed 18559094

Heyerdahl F, Hovda KE, Bjornaas MA, Brørs O, Ekeberg O, Jacobsen D (2008)
Clinical assessment compared to laboratory screening in acutely poisoned patients
Hum Exp Toxicol, 27 (1), 73-9
PubMed 18480152

Hofstad B, Nesbakken A, Eritsland J, Brørs O, Sandset PM (2008)
[Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]
Tidsskr Nor Laegeforen, 128 (21), 2440-2
PubMed 19096466

Publications 2007

Buajordet I, Laake K, Brørs O (2007)
[Can the screening of blood samples identify adverse drug reactions?]
Tidsskr Nor Laegeforen, 127 (12), 1637-9
PubMed 17571101

Publications 2006

Brørs O (2006)
[Dosaging of proton pumps inhibitors]
Tidsskr Nor Laegeforen, 126 (18), 2397-9
PubMed 16998554

Publications 2005

Hartmann S, Brørs O, Bock J, Blomhoff R, Bausch J, Wiegand UW, Hartmann D, Hornig DH (2005)
Exposure to retinyl esters, retinol, and retinoic acids in non-pregnant women following increasing single and repeated oral doses of vitamin A
Ann Nutr Metab, 49 (3), 155-64
PubMed 16006784

Hartmann S, Brørs O, Bock J, Blomhoff R, Bausch J, Wiegand UW, Hartmann D, Hornig DH (2005)
Exposure to retinoic acids in non-pregnant women following high vitamin A intake with a liver meal
Int J Vitam Nutr Res, 75 (3), 187-94
PubMed 16028634

Melien Ø, Skaali T, Myhr K, Brørs O (2005)
Venlafaxine and asthma
Nord J Psychiatry, 59 (6), 538-40
PubMed 16316911

Ranhoff AH, Brørs O (2005)
[Drugs which can cause delirium among the elderly]
Tidsskr Nor Laegeforen, 125 (17), 2366-7
PubMed 16151497

Publications 2004

Buajordet I, Naess AC, Jacobsen D, Brørs O (2004)
Adverse events after naloxone treatment of episodes of suspected acute opioid overdose
Eur J Emerg Med, 11 (1), 19-23
PubMed 15167188

Sharikabad MN, Østbye KM, Brørs O (2004)
Effect of hydrogen peroxide on reoxygenation-induced Ca2+ accumulation in rat cardiomyocytes
Free Radic Biol Med, 37 (4), 531-8
PubMed 15256224

Publications 2003

Jensen J, Sharikabad MN, Østbye KM, Melien Ø, Brørs O (2003)
Evidence that nitroprusside stimulates glucose uptake in isolated rat cardiomyocytes via mitogen-activated protein kinase
Arch Physiol Biochem, 111 (3), 239-45
PubMed 14972746

Publications 2002

Brørs O, Sharikabad MN, Jørgen J (2002)
Sarcolemmal beta-adrenoceptors determined in rat ventricular heart biopsies with (-)-[3H]CGP-12177
Pharmacol Toxicol, 91 (4), 166-73
PubMed 12530466

Buajordet I, Wesenberg F, Brørs O, Langslet A (2002)
Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital
Acta Paediatr, 91 (1), 88-94
PubMed 11883826

Dahm AE, Brørs O (2002)
[Phenytoin poisoning caused by interaction with ticlopidine]
Tidsskr Nor Laegeforen, 122 (3), 278-80
PubMed 11894596

Jensen J, Brennesvik EO, Bergersen H, Oseland H, Jebens E, Brørs O (2002)
Quantitative determination of cell surface beta-adrenoceptors in different rat skeletal muscles
Pflugers Arch, 444 (1-2), 213-9
PubMed 11976934

Krook AL, Brørs O, Dahlberg J, Grouff K, Magnus P, Røysamb E, Waal H (2002)
A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway
Addiction, 97 (5), 533-42
PubMed 12033654

Publications 2001

Brørs O (2001)
[Do thiazide diuretics cause diabetes?]
Tidsskr Nor Laegeforen, 121 (14), 1720-2
PubMed 11446018

Buajordet I, Ebbesen J, Erikssen J, Brørs O, Hilberg T (2001)
Fatal adverse drug events: the paradox of drug treatment
J Intern Med, 250 (4), 327-41
PubMed 11576320

Ebbesen J, Buajordet I, Erikssen J, Brørs O, Hilberg T, Svaar H, Sandvik L (2001)
Drug-related deaths in a department of internal medicine
Arch Intern Med, 161 (19), 2317-23
PubMed 11606147

Sharikabad MN, Ostbye KM, Brørs O (2001)
Increased [Mg2+]o reduces Ca2+ influx and disruption of mitochondrial membrane potential during reoxygenation
Am J Physiol Heart Circ Physiol, 281 (5), H2113-23
PubMed 11668073

Sharikabad MN, Ostbye KM, Lyberg T, Brørs O (2001)
Effect of extracellular Mg(2+) on ROS and Ca(2+) accumulation during reoxygenation of rat cardiomyocytes
Am J Physiol Heart Circ Physiol, 280 (1), H344-53
PubMed 11123250

Publications 2000

Brørs O (2000)
[Plasma concentration analysis of drugs by immunologic techniques]
Tidsskr Nor Laegeforen, 120 (20), 2427-9
PubMed 11475231

Sharikabad MN, Hagelin EM, Hagberg IA, Lyberg T, Brørs O (2000)
Effect of calcium on reactive oxygen species in isolated rat cardiomyocytes during hypoxia and reoxygenation
J Mol Cell Cardiol, 32 (3), 441-52
PubMed 10731443

Publications 1997

Jensen J, Aslesen R, Ivy JL, Brors O (1997)
Role of glycogen concentration and epinephrine on glucose uptake in rat epitrochlearis muscle
Am. J. Physiol.-Endocrinol. Metab., 272 (4), E649-E655

Jensen J, Aslesen R, Ivy JL, Brørs O (1997)
Role of glycogen concentration and epinephrine on glucose uptake in rat epitrochlearis muscle
Am J Physiol, 272 (4 Pt 1), E649-55
PubMed 9142887

Sharikabad MN, Cragoe EJ, Brørs O (1997)
Inhibition by 5-N-(4-chlorobenzyl)-2',4'-dimethylbenzamil of Na+/Ca2+ exchange and L-type Ca2+ channels in isolated cardiomyocytes
Pharmacol Toxicol, 80 (2), 57-61
PubMed 9060035

Publications 1996

Brørs O (1996)
[Clexane (enoxaparin) or Fragmin (dalteparin) as thrombolytics in hip surgery? Misunderstandings of the purchasing order in the municipality of Oslo]
Tidsskr Nor Laegeforen, 116 (19), 2351-2
PubMed 8804215

Stokke M, Hagelin EM, Brørs O (1996)
Effects of ATP on specific [3H](+)-isradipine binding in rat ventricular cardiomyocytes
Eur J Pharmacol, 303 (1-2), 115-22
PubMed 8804919

Stokke M, Hagelin EM, Mende U, Brørs O (1996)
Stable guanosine 5'-triphosphate-analogues inhibit specific (+)-[3H]isradipine binding in rat hearts by a Ca(2+)-lowering, G protein-independent mechanism
Pharmacol Toxicol, 78 (1), 28-36
PubMed 8685083

Stokke M, Kirkebøen KA, Naess PA, Hagelin EM, Ilebekk A, Brørs O (1996)
Equal changes in L-type calcium channel density after 60 min of ischaemia in normal and ischaemically preconditioned porcine myocardium
Acta Physiol Scand, 157 (2), 147-55
PubMed 8800354

Publications 1995

Brørs O (1995)
[Insomnia and hypnotics]
Tidsskr Nor Laegeforen, 115 (12), 1543
PubMed 7770863

Buajordet I, Ebbesen J, Erikssen J, Svaar H, Brørs O, Hilberg T (1995)
[Frequency, reporting and classification of drug-related deaths]
Tidsskr Nor Laegeforen, 115 (19), 2373-5
PubMed 7667851

Diep QN, Brørs O, Bøhmer T (1995)
Formation of pivaloylcarnitine in isolated rat heart cells
Biochim Biophys Acta, 1259 (2), 161-5
PubMed 7488636

Ebbesen J, Buajordet I, Erikssen J, Svaar H, Brørs O, Hilberg T (1995)
[Drugs as a cause of death. A prospective quality assurance project in a department of medicine]
Tidsskr Nor Laegeforen, 115 (19), 2369-72
PubMed 7667850

Hansen G, Andrew M, Bjermer L, Brørs O, Fjellbirkeland L, Johansen B, Langhammer A, Maehlumshagen G, Nguyen KN, Røyset P (1995)
[Guidelines for understanding and treating chronic obstructive lung diseases. Institute for Pharmacotherapy]
Tidsskr Nor Laegeforen, 115 (6), 710-3
PubMed 7900132

Jensen J, Brørs O, Dahl HA (1995)
Different beta-adrenergic receptor density in different rat skeletal muscle fibre types
Pharmacol Toxicol, 76 (6), 380-5
PubMed 7479580

Publications 1994

Brørs O (1994)
[Peptic ulcer. Reduced surgical needs due to pharmacological progress]
Tidsskr Nor Laegeforen, 114 (8), 903
PubMed 8191464

Stokke M, Aksnes G, Lande K, Hagelin EM, Brørs O (1994)
Density of L-type calcium channels in ischaemically preconditioned porcine heart regions
Acta Physiol Scand, 150 (4), 425-30
PubMed 8036910

Publications 1993

Brørs O, Fremstad D, Poulsson C (1993)
The affinity of human serum albumin for [3H]-digitoxin is dependent on albumin concentration
Pharmacol Toxicol, 72 (4-5), 310-3
PubMed 8372053

Publications 1992

Brørs O (1992)
[Medical consequences of medication errors]
Fag Tidsskr Sykepleien, 80 (1), 38-9
PubMed 1596418

HOLTHE MR, BRORS O, CRAGOE EJ, VEEL T, RAEDER M (1992)
DETERMINATION OF ACTIVE 5-(N,N-HEXAMETHYLENE)AMILORIDE IN PIG PLASMA
J. Chromatogr.-Biomed. Appl., 579 (2), 376-381

Holthe MR, Brørs O, Cragoe EJ, Veel T, Raeder M (1992)
Determination of active 5-(N,N-hexamethylene)amiloride in pig plasma
J Chromatogr, 579 (2), 376-81
PubMed 1429989

STOKKE M, HAGELIN EM, POULSSON C, BRORS O (1992)
CA2+ MODULATES THE INHIBITION OF (+)-[H-3]ISRADIPINE BINDING BY AMILORIDE AND QUINACRINE
Eur. J. Pharmacol.-Molec. Pharmacol. Sect., 227 (4), 379-384

Stokke M, Hagelin EM, Poulsson C, Brørs O (1992)
Ca2+ modulates the inhibition of (+)-[3H]isradipine binding by amiloride and quinacrine
Eur J Pharmacol, 227 (4), 379-84
PubMed 1332872

Stokke M, Hagelin EM, Poulsson C, Patel R, Haile Y, Brørs O (1992)
Inhibition by amiloride and quinacrine of specific [3H]nitrendipine binding to rat cardiac membranes
J Pharmacol Exp Ther, 260 (3), 1366-72
PubMed 1545399

Publications 1991

Bredesen JE, Brørs O (1991)
[Laboratory analyses in the control of narcotic abuse]
Tidsskr Nor Laegeforen, 111 (27), 3267-8
PubMed 1957280

Brørs O (1991)
[Subarachnoid hemorrhage. Treatment with nimodipine--a new calcium antagonist of dihydropyridine type]
Tidsskr Nor Laegeforen, 111 (18), 2273-4
PubMed 1896984

Brørs O (1991)
Effect of furosemide, hydrochlorothiazide and sodium restriction on rat adrenoceptors
Pharmacol Toxicol, 69 (3), 167-72
PubMed 1796058

Brørs O, Gadeholt G (1991)
[Tablet strength and dosage of thiazides in hypertension must be reduced]
Tidsskr Nor Laegeforen, 111 (13), 1656-7
PubMed 2063371

Kvien TK, Brørs O, Staff PH, Rognstad S, Nordby J (1991)
Improved cost-effectiveness ratio with a patient self-adjusted naproxen dosing regimen in osteoarthritis treatment
Scand J Rheumatol, 20 (4), 280-7
PubMed 1925416

Publications 1990

Gadeholt G, Brørs O (1990)
[Life with and without Halcion]
Tidsskr Nor Laegeforen, 110 (7), 878-9
PubMed 2321219

Publications 1989

Brørs O, Sandnes D (1989)
Effect of diuretics on adrenergic receptors in the rat
Pharmacol Toxicol, 65 (4), 249-51
PubMed 2587507

Theodoresen L, Brørs O (1989)
The importance of lipid solubility and receptor selectivity of beta-adrenoceptor blocking drugs for the occurrence of symptoms and side-effects in out-patients
J Intern Med, 226 (1), 17-23
PubMed 2569025

Publications 1988

Brørs O (1988)
[Pharmacotherapy in anxiety. Guidelines from a Swedish working group]
Tidsskr Nor Laegeforen, 108 (19-21), 1518
PubMed 3388392

Publications 1987

Brors O (1987)
Gastrointestinal mucosal lesions. A drug formulation problem
Med Toxicol, 2 (2), 105-11
PubMed 3553832

Brørs O, Lilleng R, Søyland K, Holm H (1987)
Effect of acute potassium depletion and thiazide treatment on blood glucose in the normal rat
Res Commun Chem Pathol Pharmacol, 58 (2), 277-80
PubMed 3423425

Kvien TK, Rugstad HE, Brørs O (1987)
[Antiphlogistics in musculoskeletal diseases]
Tidsskr Nor Laegeforen, 107 (9), 861-2
PubMed 3590127

Publications 1986

Brørs O (1986)
[Gastrointestinal symptoms induced by the adverse effects of oral potassium preparations]
Tidsskr Nor Laegeforen, 106 (31), 2641-2
PubMed 3810582

Grotmol T, Buanes T, Brørs O, Raeder MG (1986)
Lack of effect of amiloride, furosemide, bumetanide and triamterene on pancreatic NaHCO3 secretion in pigs
Acta Physiol Scand, 126 (4), 593-600
PubMed 2424271

Publications 1985

Brørs O, Jacobsen S (1985)
pH lability in serum during equilibrium dialysis
Br J Clin Pharmacol, 20 (1), 85-8
PubMed 4027141

Publications 1983

Baekkevar M, Brørs O (1983)
[Acidosis with fatal outcome in a patient with renal insufficiency and glaucoma after treatment with acetazolamide]
Tidsskr Nor Laegeforen, 103 (6), 617-8
PubMed 6868040

Brørs O, Sager G, Sandnes D, Jacobsen S (1983)
Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis
Br J Clin Pharmacol, 15 (4), 393-7
PubMed 6849773

Lilleng R, Brørs O, Jacobsen S, Søyland K, Holm H (1983)
Lack of hyperglycemic effect of chlorothiazide in normal rats fed diets with different carbohydrate content
Res Commun Chem Pathol Pharmacol, 42 (3), 497-500
PubMed 6665305

Publications 1982

Brørs O (1982)
Pharmacokinetics of hydroflumethiazide during repeated administration in congestive heart failure
Acta Pharmacol Toxicol (Copenh), 51 (3), 177-81
PubMed 7136723

Brørs O, Braut GS, Braut S, Jacobsen S (1982)
Interaction of hydroflumethiazide and 2,4-disulfamyl-5-trifluoromethylaniline with cyclic AMP phosphodiesterase and carbonic anhydrase
Acta Pharmacol Toxicol (Copenh), 51 (4), 273-7
PubMed 6295063

Publications 1981

Brørs O, Enger E, Jacobsen S, Aakvaag A, Foss OP (1981)
Effects of hydroflumethiazide in congestive heart failure: renal electrolyte excretion related to urinary thiazide excretion and aldosterone
Acta Pharmacol Toxicol (Copenh), 49 (5), 399-406
PubMed 7345881

Brørs O, Jacobsen S, Foss OP, Aakvaag A (1981)
Effect of repeated doses of hydroflumethiazide on renal excretion of electrolytes and uric acid in healthy subjects
Acta Pharmacol Toxicol (Copenh), 48 (2), 145-50
PubMed 7257825

Publications 1980

Brørs O, Fauchald P, Lind E, Jacobsen S (1980)
Pharmacokinetics and saluretic effect of muzolimine in severe cardiac failure
Curr Med Res Opin, 6 (6), 431-6
PubMed 7363644

Lunde PK, Lange-Nielsen F, Brørs O (1980)
[Theophyllin-dosage in adults; blood level determination as therapeutic control]
Tidsskr Nor Laegeforen, 100 (3), 173-74
PubMed 7385143

Publications 1979

Brørs O (1979)
[Guidelines for choice of diuretics]
Tidsskr Nor Laegeforen, 99 (9-10), 486
PubMed 442047

Brørs O, Haffner JF, Jacobsen S (1979)
Excretion of hydroflumethiazide in bile and urine of man
Eur J Clin Pharmacol, 15 (4), 287-9
PubMed 477714

Brørs O, Jacobsen S (1979)
Pharmacokinetics of hydroflumethiazide during repeated oral administration to healthy subjects
Eur J Clin Pharmacol, 15 (4), 281-6
PubMed 477713

Brørs O, Jacobsen S (1979)
Distribution of elimination of hydroflumethiazide in man
Eur J Clin Pharmacol, 16 (2), 125-31
PubMed 499309

Brørs O, Jacobsen S, Arnesen E (1979)
Pharmacokinetics of a single oral dose of muzolimine in cardiac failure
Eur J Clin Pharmacol, 15 (2), 105-8
PubMed 436918

Publications 1978

Brørs O (1978)
[Comparison between intravenous administration of salbutamol and theophylline in asthma]
Tidsskr Nor Laegeforen, 98 (12), 642
PubMed 653667

Brørs O, Jacobsen S, Arnesen E (1978)
Pharmacokinetics of a single oral dose of hydroflumethiazide in health and in cardiac failure.-
Eur J Clin Pharmacol, 14 (1), 29-37
PubMed 729604

Publications 1977

Brors O (1977)
[Problems with potassium in treatment with diuretics]
Tidsskr Nor Laegeforen, 97 (30), 1581-2
PubMed 929538

Brors O, Jacobsen S, Arnesen E (1977)
Fluorometric determination of hydroflumethiazide in human plasma and urine after its oral administration
Eur J Clin Pharmacol, 11 (2), 149-54
PubMed 837968

Publications 1970

Brors O, Jacobsen S (1970)
Ionic basis of bradykinin action on the rat uterus
Acta Pharmacol Toxicol (Copenh), 28 (1), 41
PubMed 5314418